Posts With Tag PolyPid Ltd

Explore PolyPid Ltd.'s February 2025 Form 6-K report detailing new director Yitzchak Jacobovitz's appointment and key financial updates for Q4 2024.

PolyPid Ltd. addresses Nasdaq compliance with a $14.5M PIPE, raising equity to $7.5M. Future trial results may influence further growth.

Explore PolyPid Ltd.'s Form 6-K detailing a $14.5M private placement to support SHIELD II Phase 3 trials, with potential additional $27M from warrants. Key financial insights included.